Actero Pharma

Actero Pharma is a specialty pharmaceutical company focused on the commercialization of innovative therapies for patients with unmet medical needs, particularly in the neurology and specialty care sectors. The company is best known for its strategic partnership with Aquestive Therapeutics to commercialize Sympazan (clobazam) oral film for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS). Actero leverages a targeted commercial infrastructure to bring specialty products to market, focusing on niche therapeutic areas where patient needs are underserved. The company operates as a private entity, utilizing a lean business model to drive growth through partnerships and product acquisitions. By focusing on patient-centric solutions and efficient market access, Actero aims to improve outcomes for individuals living with complex chronic conditions.